The article presents a case of a 4-year old boy with precursor-B acute lymphoblastic leukemia (ALL). The National Cancer Institutes pointed out that the boy had no central nervous system (CNS) disease. A salvage therapy using single agent Rituximab was administered. Key information about findings and results is presented.